Search Within

Alan H Shih

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (6)
Groups
  1. Adult Leukemia (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. Executive Committee, Center for Hematologic Malignancies (15)
  5. GSK Faculty (15)
  6. Hematologic Malignancies, Division of (15)

More Groups

People
  1. Ross Levine (15)
  2. Omar Abdel-Wahab (8)
  3. Elodie Pronier (5)
  4. Jay Patel (5)
  5. Martin Tallman (5)
  6. Suveg Pandey (5)

More People

Years
  1. 2023 (1)
  2. 2018 (3)
  3. 2017 (2)
  4. 2016 (1)
  5. 2015 (1)
  6. 2014 (2)

More Years

Publications
  1. Blood (6)
  2. Cancer Cell (4)
  3. Cancer Discovery (1)
  4. Cell Reports (1)
  5. Experimental Hematology (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Cell Press (5)
  3. American Association for Cancer Research (1)
  4. Elsevier Science, Inc. (1)
  5. Nature Publishing Group (1)
  6. Rockefeller University Press (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Vela, P. S.; Wang, R.; Tran, D.; Benitez, A. M.; Krishnan, A.; O'Connor, K.; Liu, W.; Kleppe, M.; Bowman, R.; Cai, S.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
    Journal Article

    Kunimoto, H.; Meydan, C.; Nazir, A.; Whitfield, J.; Shank, K.; Rapaport, F.; Maher, R.; Pronier, E.; Meyer, S. C.; Garrett-Bakelman, F. E.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
    Journal Article

    Intlekofer, A. M.; Shih, A. H.; Wang, B.; Nazir, A.; Rustenburg, A. S.; Albanese, S. K.; Patel, M.; Famulare, C.; Correa, F. M.; Takemoto, N.; more...
    Nature (2018)

    Fulltext@MSK | Save
  • Spliceosomal dysfunction Is a critical mediator of IDH2 mutant leukemogenesis
    Meeting Abstract

    Yoshimi, A.; Lin, K. T.; Wiseman, D.; Intlekofer, A. M.; Wang, B.; Pastore, A.; Rahman, M.; Lee, S. C. W.; Liu, B.; Micol, J. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells
    Journal Article

    Kunimoto, H.; McKenney, A. S.; Meydan, C.; Shank, K.; Nazir, A.; Rapaport, F.; Durham, B.; Garrett-Bakelman, F. E.; Pronier, E.; Shih, A. H.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
    Meeting Abstract

    Kunimoto, H.; Meydan, C.; Nazir, A.; Shank, K.; Maher, R.; Rapaport, F.; Pronier, E.; Melnick, A.; Levine, R. L.; Shih, A. H.
    Blood (2016)

    Fulltext@MSK | Save
  • CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
    Journal Article

    Meyer, S.; Keller, M.; Chiu, S.; Koppikar, P.; Guryanova, O.; Rapaport, F.; Xu, K.; Manova, K.; Pankov, D.; O'reilly, R.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid lukemia
    Meeting Abstract

    Rampal, R. K.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J. P.; Li, Y. S.; Ahn, J.; Abdel-Wahab, O.; Shih, A. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia
    Journal Article

    Rampal, R.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J.; Li, Y.; Ahn, J.; Abdel-Wahab, O.; Shih, A.; more...
    Cell Reports (2014)

    Fulltext@MSK | Save